Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Modulift Vertebral Body Replacement (VBR) System

K-Number: K172032 · 2017-11-20

ApplicantAesculap Implants Systems, Inc.
Decision Date2017-11-20
Product CodePLR
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

Modulift Vertebral Body Replacement (VBR) System is a medical device manufactured by Aesculap Implants Systems, Inc.. It received FDA 510(k) clearance on 2017-11-20 under approval number K172032. The device is classified under product code PLR. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Modulift Vertebral Body Replacement (VBR) System?

Modulift Vertebral Body Replacement (VBR) System is a medical device that received FDA 510(k) clearance on 2017-11-20. It is manufactured by Aesculap Implants Systems, Inc.. The 510(k) number is K172032.

When was Modulift Vertebral Body Replacement (VBR) System approved by the FDA?

Modulift Vertebral Body Replacement (VBR) System received FDA 510(k) clearance on 2017-11-20, under approval number K172032.

What company makes Modulift Vertebral Body Replacement (VBR) System?

Modulift Vertebral Body Replacement (VBR) System is manufactured by Aesculap Implants Systems, Inc..

What is the FDA product code for Modulift Vertebral Body Replacement (VBR) System?

The FDA product code for Modulift Vertebral Body Replacement (VBR) System is PLR.

Related Clinical Trials

NCT05508360 "Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nulcectomy" (LOPAIN2) RECRUITING NCT07601269 Replacement of the Native Mitral Valve Using the ReValve System RECRUITING NCT06414265 Reduction of Mitral Regurgitation With the SATURN Trans-Septal Transcatheter Mitral Valve Replacement (TMVR) System in Patients With Severe Symptomatic Mitral Regurgitation RECRUITING NCT06608823 ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™ RECRUITING NCT03242642 Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation. RECRUITING NCT07276711 CAPTURE-2: Controlled Arterial Protection to Ultimately Remove Embolic Material RECRUITING

Related Devices (Code: PLR)

K152568C-VBRCardinal Spine, LLC K180550NuVasive Monolith Cervical Corpectomy SystemNu Vasive, Incorporated K173893TrabisColigne AG K180673Normandy VBR SystemZavation Medical Products, LLC K190284Bengal Stackable Cage SystemMedos International SARL K190426ALTA Anterior Cervical Corpectomy SystemAstura Medical, LLC

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑